Product Recalls in California

Product recalls affecting California — including food, drugs, consumer products, medical devices, and vehicles distributed to California. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 3,040 recalls have been distributed to California in the last 12 months.

56,506 total recalls
3,040 in last 12 months

Showing 61816200 of 13,703 recalls

DrugFebruary 4, 2019· ICU Medical Inc

Recalled Item: 0.9% Sodium Chloride Injection Recalled by ICU Medical Inc Due to CGMP...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 1, 2019· Mylan Institutional Inc

Recalled Item: Levoleucovorin Injection Recalled by Mylan Institutional Inc Due to Presence...

The Issue: Presence of Particulate Matter: particulate matter identified as copper salts

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 1, 2019· Mylan Pharmaceuticals Inc.

Recalled Item: Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray...

The Issue: Defective Container: Potential for broken glass in the neck area of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 31, 2019· Dr. Reddy's Laboratories, Inc.

Recalled Item: Divalproex Sodium Extended-release Tablets Recalled by Dr. Reddy's...

The Issue: Failed Dissolution Specifications: Out of specification results observed for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 30, 2019· Valeant Pharmaceuticals North America LLC

Recalled Item: Diltiazem HCl CD capsules Recalled by Valeant Pharmaceuticals North America...

The Issue: Failed Dissolution Specifications: high out of specification results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 30, 2019· Valeant Pharmaceuticals North America LLC

Recalled Item: Cardizem CD (diltiazem HCl) capsules Recalled by Valeant Pharmaceuticals...

The Issue: Failed Dissolution Specifications: high out of specification results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 30, 2019· Valeant Pharmaceuticals North America LLC

Recalled Item: Cardizem CD (diltiazem HCl) capsules Recalled by Valeant Pharmaceuticals...

The Issue: Failed Dissolution Specifications: high out of specification results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 30, 2019· Valeant Pharmaceuticals North America LLC

Recalled Item: Cardizem CD (diltiazem HCl) capsules Recalled by Valeant Pharmaceuticals...

The Issue: Failed Dissolution Specifications: high out of specification results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 30, 2019· Valeant Pharmaceuticals North America LLC

Recalled Item: Cardizem CD (diltiazem HCl) capsules Recalled by Valeant Pharmaceuticals...

The Issue: Failed Dissolution Specifications: high out of specification results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 29, 2019· US Compounding Inc

Recalled Item: Ephedrine Sulfate Recalled by US Compounding Inc Due to Lack of assurance of...

The Issue: Lack of assurance of sterility.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 28, 2019· Lupin Pharmaceuticals Inc.

Recalled Item: Bimatoprost Ophthalmic Solution 0.03% Recalled by Lupin Pharmaceuticals Inc....

The Issue: Failed Impurities/Degradation Specifications: OOS results observed in any...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 25, 2019· Akorn Inc

Recalled Item: Clobetasol Propionate Emollient Cream 0.05% Recalled by Akorn Inc Due to...

The Issue: Failed Stability Specification; out of specification (OOS) results for a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 24, 2019· US Compounding Inc

Recalled Item: LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%)...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 24, 2019· Sun Pharmaceutical Industries, Inc.

Recalled Item: BromSite (bromfenac ophthalmic solution) 0.075% Recalled by Sun...

The Issue: Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Alprazolam Tablets Recalled by Mylan Institutional, Inc. (d.b.a. UDL...

The Issue: Failed Impurities/Degradation Specifications: Elevated levels of a known...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Prinston Pharmaceutical Inc

Recalled Item: Irbesartan and Hydrochlorothiazide Tablets Recalled by Prinston...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Mylan Pharmaceuticals Inc.

Recalled Item: Fexofenadine HCl Tablets Recalled by Mylan Pharmaceuticals Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications: Related compound results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Prinston Pharmaceutical Inc

Recalled Item: Irbesartan Tablets 300 mg 90 count Rx only Manufactured by: Recalled by...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Prinston Pharmaceutical Inc

Recalled Item: Irbesartan and Hydrochlorothiazide Tablets Recalled by Prinston...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 18, 2019· Prinston Pharmaceutical Inc

Recalled Item: Irbesartan and Hydrochlorothiazide Tablets Recalled by Prinston...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund